Navigating the FDA Regulatory Processes : An Integrated Clinical and Engineering Approach

個数:
電子版価格
¥20,871
  • 電子版あり

Navigating the FDA Regulatory Processes : An Integrated Clinical and Engineering Approach

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 252 p.
  • 言語 ENG
  • 商品コード 9781482207088
  • DDC分類 615.1900973

Full Description

This book provides a unique knowledge source of the FDA's regulatory processes to anyone interested in the development and approval of biomedical products.

Navigating the FDA Regulatory Processes will be of particular importance for those innovating in biomedical devices, pharmacological therapies, and combination products, who are interested in considering regulatory affairs early on in product development. The authors offer a comprehensive exploration of FDA regulations, providing industry insights and guidance for navigating the complexities of drug and device development. The book offers concrete examples, industry perspectives, and historical context, ensuring clarity and aiding in successful understanding of the requirements for regulatory compliance. Readers will also gain a thorough understanding of FDA regulatory processes, from securing approvals to navigating expedited pathways. Lastly, the book provides unique insights into the FDA approach for emergency preparedness, including discussing the recent COVID-19 pandemic.

Biomedical industry personnel, engineers, scientists, entrepreneurs, medical doctors, students, and anyone interested in the development and approval of medical products in the US will find this book useful and essential.

Contents

Chapter 1- Introduction
Pablo Gurman, Yitzhak Rosen, and Noel M. Elman

Chapter 2- Dancing with the FDA: Managing Expectations
Raymond Vennare

Chapter 3- New Drug Application
Harvey M. Arbit and Wrenda Teeple

Chapter 4- Basics of Generic Drug Regulation
Giridhar Prasad and Anurag Patel

Chapter 5- Introduction to Medical Device Regulation
Anurag Patel

Chapter 6- FDA and Regulation of Biologics
Oliver V. Cácananta

Chapter 7- Combination Products
Evan B. Siegel

Chapter 8- FDA Expedited Pathways
Oliver V. Cácananta

Chapter 9- Investigator-Initiated Sponsored Research
Harvey M. Arbit and Wrenda Teeple

Chapter 10- Medical Countermeasures for Public Health Emergency Preparedness and Response in The United States: A Regulatory Perspective
Angela Bellos, Jack Russell, and Doris Snow

最近チェックした商品